Radioimmunotherapy [radioimunoterapie]
- Terms
-
Immunoradiotherapy
Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
- Annotation
- coordinate with disease /radiother
- DUI
- D016499 MeSH Browser
- CUI
- M0025194
- Previous indexing
- Antibodies, Monoclonal/therapeutic use (1984-1991); Immunotherapy (1984-1991); specific radioisotope/therapeutic use (1981-1991)
- History note
- 92
- Public note
- 92
Allowable subheadings
- AE
- adverse effects 2
- CL
- classification
- EC
- economics
- ES
- ethics
- HI
- history
- IS
- instrumentation 1
- MT
- methods 23
- MO
- mortality
- NU
- nursing
- PX
- psychology
- ST
- standards
- SN
- statistics & numerical data
- TD
- trends 2
- VE
- veterinary